Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 21, 2017; 23(35): 6412-6419
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412
Figure 1 General observations of the rat model of liver fibrosis/cirrhosis.
A: Healthy control group; B: TAA group; C: TAA + low-dose aspirin group; D: TAA + high-dose aspirin group; and E: TAA + enoxaparin group. TAA: Thioacetamide.
- Citation: Li CJ, Yang ZH, Shi XL, Liu DL. Effects of aspirin and enoxaparin in a rat model of liver fibrosis. World J Gastroenterol 2017; 23(35): 6412-6419
- URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6412.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i35.6412